First Peanut Allergy Drug Approved by FDA for Kids

by Iswarya on  February 4, 2020 at 3:06 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

In a new, groundbreaking development in the fight against food allergies, the Food and Drug Administration (FDA) approved the first treatment for children with peanut allergies.
First Peanut Allergy Drug Approved by FDA for Kids
First Peanut Allergy Drug Approved by FDA for Kids

Treatment with the drug, Palforzia, can be used for children between 4 and 17 years old with a confirmed diagnosis of peanut allergy, the FDA said in a statement.

Show Full Article


The drug is designed to minimize the incidence and severity of a child''s allergic reaction to peanuts, as even a small amount of exposure can be harmful to children with the allergy.

"When used in conjunction with peanut avoidance, Palforzia provides an FDA-approved treatment option to help reduce the risk of these allergic reactions in children with peanut allergy," said Peter Marks, director of the FDA''s Center for Biologics Evaluation and Research.

Palforzia is a powder manufactured from peanuts and packaged in pull-apart capsules and a sachet, according to the FDA.

The powder is emptied from the capsules or sachet and mixed with a small amount of semisolid food -- such as applesauce, yogurt, or pudding.

The effectiveness of Palforzia is supported by a randomized, double-blind, placebo-controlled study conducted in the US, Canada, and Europe in approximately 500 peanut-allergic individuals.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive